As of May 13, 2025, the QGEN stock has a PE ratio of 97.93. The calculation is based on the latest EPS of $0.43 and the stock price of $42.11 per share. A decrease of 15% has been observed in the PE ratio compared to its average of 115.4 of the last four quarters.
The mean historical PE ratio of Qiagen over the last ten years is 82.6. The current 97.93 P/E ratio is 19% higher than the historical average. Looking back at the last ten years, QGEN's PE ratio peaked in the Jun 2020 quarter at 882.68, with a price of $44.13 and an EPS of $0.05. The Sep 2021 quarter marked the lowest point at 19.81, with a price of $53.28 and an EPS of $2.69.
Maximum annual increase: 292.56% in 2024
Maximum annual decrease: -75.68% in 2018
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 117.18 | 292.56% | $44.53 | $0.38 |
2023 | 29.85 | 8% | $44.77 | $1.5 |
2022 | 27.64 | 8.52% | $51.41 | $1.86 |
2021 | 25.47 | -24.26% | $57.3 | $2.25 |
2020 | 33.63 | N/A | $54.49 | $1.62 |
2019 | N/A | N/A | $34.85 | -$0.19 |
2018 | 40.82 | -75.68% | $35.52 | $0.87 |
2017 | 167.83 | 95.81% | $31.89 | $0.19 |
2016 | 85.71 | 67.93% | $30 | $0.35 |
2015 | 51.04 | 5.67% | $29.6 | $0.58 |
2014 | 48.3 | -39.37% | $25.12 | $0.52 |
2013 | 79.66 | 141.91% | $25.49 | $0.32 |
2012 | 32.93 | -1.99% | $19.43 | $0.59 |
2011 | 33.6 | 5.96% | $14.79 | $0.44 |
2010 | 31.71 | -4.49% | $20.93 | $0.66 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 93.37 | -20.32% | $40.15 | $0.43 |
Dec 2024 | 117.18 | 2.85% | $44.53 | $0.38 |
Sep 2024 | 113.93 | -16.82% | $45.57 | $0.4 |
Jun 2024 | 136.97 | 371.5% | $41.09 | $0.3 |
Mar 2024 | 29.05 | -2.68% | $42.99 | $1.48 |
Dec 2023 | 29.85 | 0.81% | $44.77 | $1.5 |
Sep 2023 | 29.61 | -8.16% | $41.75 | $1.41 |
Jun 2023 | 32.24 | 3.5% | $46.42 | $1.44 |
Mar 2023 | 31.15 | 12.7% | $47.35 | $1.52 |
Dec 2022 | 27.64 | 31.18% | $51.41 | $1.86 |
Sep 2022 | 21.07 | -2.59% | $42.56 | $2.02 |
Jun 2022 | 21.63 | 1.07% | $48.66 | $2.25 |
Mar 2022 | 21.4 | -15.98% | $50.52 | $2.36 |
Dec 2021 | 25.47 | 28.57% | $57.3 | $2.25 |
Sep 2021 | 19.81 | -13.42% | $53.28 | $2.69 |
The current PE ratio of QGEN is higher than its 3, 5 and 10-year averages.
QGEN's PE ratio stands higher than its peer stocks GE and TMO. Qiagen's current PE ratio of 97.93 is higher than the average of its peers, which is 35.84.
Stock name | PE ratio | Market cap |
---|---|---|
HOLX Hologic Inc | 23.36 | $12.44B |
TMO Thermo Fisher Scientific Inc | 24.29 | $156.71B |
BDX Becton Dickinson & Co | 33.07 | $49.1B |
GE General Electric Co | 34.26 | $236.76B |
TECH BIO-TECHNE Corp | 59.35 | $7.72B |
QGEN Qiagen NV | 97.65 | $9.14B |
The price to earnings ratio for QGEN stock is 97.93 as of May 13, 2025.
The average PE ratio for QGEN stock over the past 3 years is 56.97.
The average PE ratio for QGEN stock over the past 5 years is 88.81.
The highest quarterly PE ratio in the last ten years has been 882.68 and it was in the Jun 2020 quarter.
QGEN's current price to earnings ratio is 19% above its 10-year historical average.
QGEN's PE ratio of 97.93 is considered high because the company's stock price is trading at a higher multiple of earnings.
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (May 13, 2025), Qiagen's share price is $42.11. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.43. Therefore, Qiagen's PE ratio for today is 97.93. PE RATIO(97.93) = STOCK PRICE($42.11) / TTM EPS($0.43)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.